Treasury Analyst - Reading, Berkshire, RG1 8DB Contract: PermanentSalary: Competitive salary circa 55,000 per annum, depending on experienceThis is a broad and exciting Treasury Analyst front office role at the UKs largest Water and Wastewater Company,
Management Accountant - Reading, Berkshire, RG1 8DB Contract: PermanentSalary: Offering up to 65,000 per annum As a Management Accountant, youll play a key role in delivering accurate financial reporting and insightful analysis for the Water business. Youll
Machine Tool Engineers - Reading, Berkshire,RG7 4PR Job Type:Full-TimeSalary: 44000 - 55000 per annum + Pension Closing date: 4th August 2026 (We would encourage you to apply as soon as possible, as roles will be filled
Machine Tool Engineers - Reading, Berkshire,RG7 4PR Job Type:Full-TimeSalary: 44000 - 55000 per annum + Pension Role title: Machine Tool Engineers Closing date: 4th August 2026 (We would encourage you to apply as soon as possible,
Information Technology Service Delivery Manager IT Service Delivery Manager Location: Watford (Hybrid 3 days office based and 2 days working from home) Salary: Competitive + Benefits Closing date: 31st July 2026 About Us At Corona Energy,
KTP Associate in Power Electronics - Tridonic -Sutherland Building, Newcastle upon Tyne, Tyne and Wear, NE1 8ST, GB Salary: 40,000 - 41,800Work hours: Office Hours Monday to Friday, Full Time Job Description ABOUT THE ROLE Working
Research Fellow in Nursing -Coach Lane Campus, Newcastle upon Tyne, Tyne and Wear, NE7 7XA, GB Salary: 41,064 - 46,049 pro rataWork hours: Office Hours Monday to Friday, Part Time Job Description ABOUT THE ROLE Are
Senior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address
Scientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs